Abstract
Male breast cancer is a rare disease and clinical or epidemiological data are available from only a relatively few cases. Nonetheless, both similarities and discrepancies are apparent between breast cancer in men and women. For example, lobular and mucinous carcinomas are seldom seen in men. Tumors in men more often display neuroendocrine differentiation, with an average age at diagnosis ten years later than in women. A high proportion of breast tumors in men are estrogen receptor-α positive (in this review 77%) and progesterone receptor positive (76%). Breast tumors in men often respond favorably to endocrine manipulation, including testicular ablation or antiestrogen therapy. Thus, the hormone receptors in these tumors can be functionally active and used for therapeutic intervention. This proposal has been questioned in some studies because estrogen dependent proteins are expressed to a lesser degree in men. Furthermore, men do not have a better overall breast cancer prognosis compared with women, after adjustments have been made for age and tumor stage. While the androgen receptor content has been assessed in a few studies, there are no studies on the estrogen receptor-β content of breast tumors in men.
Similar content being viewed by others
REFERENCES
R. W. Crichlow and S. W. Galt (1990). Male breast cancer. Surg. Clin. North Am. 70(5):1165–1177.
H. Olsson (1990). Reproductive and hormonal factors in relation to cancer occurrence in the breast, cervix and corpus uteri, testis, prostate and the thyroid gland. In B. Nordenskjöld, A. Macieira-Coelho, (eds.), Cancer and Aging, CRC Press Boca Raton, Florida pp. 109–126.
P. P. Rosen, C. J. Menendez-Botet, J. S. Nisselbaum, M. K. Schwartz, and J. A. Urban (1976). Estrogen receptor protein in lesions of the male breast. A preliminary report. Cancer 37:1866–1868.
Y. Nomura, H. Kondo, J. Yamagata, and K. Takenaka (1977). Detection of the estrogen receptor and response to endocrine therapy in male breast cancer patients. Gann 68:333–336.
M. J. Duffy and G. J. Duffy (1978). Multiple steroid receptors in male breast carcinomas. Clin. Chim. Acta 85(2):211–214.
N. Gupta, J. L. Cohen, C. Rosenbaum, and S. Raam (1980). Estrogen receptors in male breast cancer. Cancer 46(8):1781–1784.
R. B. Everson, M. E. Lippman, E. B. Thompson, W. L. McGuire, J. L. Wittliff, E. R. De Sombre, E. V. Jensen, A. Singhakowinta, S. C. Brooks, Jr., and J. P. Neifeld (1980). Clinical correlations of steroid receptors and male breast cancer. Cancer Res. 40(4):991–997.
H. S. Ellison, S. A. Scheuer, and E. R. Eichner (1980). Metastatic breast carcinoma with positive estrogen and progesterone receptors in a man with Klinefelter's syndrome. South Med. J. 73(10):1393–1396.
C. Silfverswärd, J-Å. Gustafsson, S. A. Gustafsson, S. Humla, B. Nordenskjöld, A. Wallgren, and Ö. Wrange (1980). Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer. Cancer 45:2001–2005.
S. J. Ruff, J. E. Bauer, E. J. Keenan, H. S. Moseley, and W. S. Fletcher (1981). Hormone receptors in male breast carcinoma. J. Surg. Oncol. 18(1):55–59.
M. A. Friedman, P. G. Hoffman, Jr., E. M. Dandolos, M. D. Lagios, W. H. Johnston, and P. K. Siiteri (1981). Estrogen receptors in male breast cancer: Clinical and pathologic correlations. Cancer 47(1):134–137.
R. J. Pegoraro, D. Nirmul, and S. M. Joubert (1982). Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer. Cancer Res. 42(11):4812–4814.
R. J. Mercer, R. M. Bryan, and R. C. Bennett (1984). Hormone receptors in male breast cancer. Aust. N. Z. J. Surg. 54(3):215–218.
M. M. Pacheco, C. F. Oshima, M. P. Lopes, A. Widman, E. L. Franco, and M. M. Brentani (1986). Steroid hormone receptors in male breast diseases. Anticancer Res. 6(5):1013–1017.
R. N. Xu (1989). [Male breast cancer: Clinical, pathologic and immunohistochemical study]. Chung Hua Wai Ko Tsa Chih 27(1):28–30, 61.
Z. Sulyok and I. Koves (1993). Male breast tumors. Eur. J. of Surg. Oncol. 19(6):581–586.
H. Stalsberg, D. B. Thomas, K. A. Rosenblatt, L. M. Jimenez, A. McTiernan, A. Stemhagen, W. D. Thompson, M. G. McCrea Curnen, W. Satariano, D. F. Austin, R. S. Greenberg, C. Key, L. Kolonel, and D. West (1993). Histologic types and hormone receptors in breast cancer in men: A populationbased study in 282 U.S. men. Cancer Causes Control 4(2):143–151.
K. Weber-Chappuis, S. Bieri-Burger, and J. Hurlimann (1996). Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas. Eur. J. Cancer 32A(10):1686–1692.
W. L. Williams, Jr., M. Powers, and L. D. Wagman (1996). Cancer of the male breast: A reviw. J. Natl. Med. Assoc. 88(7):439–443.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Olsson, H. Estrogen Receptor Content in Malignant Breast Tumors in Men—a Review. J Mammary Gland Biol Neoplasia 5, 283–287 (2000). https://doi.org/10.1023/A:1009546811429
Issue Date:
DOI: https://doi.org/10.1023/A:1009546811429